Abstract
The results of the first double-blind placebo-controlled trial using grafts of embryonic tissue to treat Parkinson's disease have aroused widespread interest and debate about the future of cell replacement therapies. What are the key issues that need to be resolved and the directions in which this technology is likely to develop?
MeSH terms
-
Animals
-
Brain Tissue Transplantation / adverse effects
-
Brain Tissue Transplantation / statistics & numerical data*
-
Brain Tissue Transplantation / trends*
-
Clinical Trials as Topic / statistics & numerical data
-
Clinical Trials as Topic / trends
-
Humans
-
Parkinson Disease / pathology
-
Parkinson Disease / physiopathology
-
Parkinson Disease / surgery*
-
Stem Cell Transplantation
-
Treatment Outcome